Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse

Recruiting now

Conditions studied: Mitral Valve Prolapse

In brief

This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision making between these two therapies and assist providers in integrating shared decision making the within the multidisciplinary heart valve team.

Key facts

Study ID

NCT06738537

Run by

Northwell Health

People needed

150

Starts

2023-09-01

Expected to finish

2025-02-28

Last updated by the study team

2024-12-17

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 21 years and older
• Diagnosis of degenerative mitral valve regurgitation

You may not qualify if…

• Non-English speaking
• Unable to consent on own behalf
• Previous mitral surgery

Where it is running

• Cedars-Sinai Medical Center — Los Angeles, California, United States (enrolling)
• Saint Luke's Hospital — Kansas City, Missouri, United States (enrolling)
• Northwell Health — New York, New York, United States (enrolling)
• Cleveland Clinic — Cleveland, Ohio, United States (enrolling)
• West Virginia University Medicine — Morgantown, West Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.